Ronald E. Painter
Quantitative BioSciences(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Microbial Natural Products and Biosynthesis, RNA and protein synthesis mechanisms, Antibiotics Pharmacokinetics and Efficacy, Cancer therapeutics and mechanisms
Most-Cited Works
- → Platensimycin is a selective FabF inhibitor with potent antibiotic properties(2006)810 cited
- → Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center(2004)443 cited
- → Selective small-molecule inhibition of an RNA structural element(2015)415 cited
- → Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties(2007)380 cited
- → Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy(2017)331 cited
- → Discovery of FabH/FabF Inhibitors from Natural Products(2006)199 cited
- → A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier(2019)190 cited
- → Discovery of Kibdelomycin, A Potent New Class of Bacterial Type II Topoisomerase Inhibitor by Chemical-Genetic Profiling in Staphylococcus aureus(2011)163 cited
- → Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®(2014)159 cited
- → In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa(2019)121 cited